Ipragliflozin is a medication used to treat type 2 diabetes. However, during its manufacturing process, impurities may be formed. These impurities can affect the quality and safety of the medication. It is important to monitor and control the levels of these impurities to ensure the effectiveness of the medication and minimize potential risks to patients.